SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613
MerckSARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613
SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613
SARS-CoV-2 Spike (RBD, aa 331-524) Recombinant Antigen
SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen
Use the Bio-Plex Pro Human Serology Reagent when performing Bio-Plex Pro singleplex or combined (multiplexed) assays with Bio-Plex SARS-CoV-2 N, RBD, S1, and/or S2, and/or nucleocapsid coupled magnetic beads and Human IgA, IgG, or IgM detection in human and non-human primate samples.
Provides sensitive and specific quantitation of antibodies against four SARS-CoV-2 proteins: nucleocapsid, receptor binding domain, spike 1, and spike 2 viral proteins.
Protein Biomarker Testing and Custom Assay Development Services
Glial Fibrillary Acidic Protein (GFAP) is a class-III intermediate filament majorly expressed in astrocytic glial cells in the central nervous system. Astrocytes play a variety of key roles in supporting, guiding, nurturing, and signaling neuronal architecture and activity. Monomeric GFAP is about 55kD. It is capable of forming both homodimers and heterodimers; GFAP can polymerize with other type III proteins or with neurofila…
The Simoa Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are Abeta 40 (Aβ40), Abeta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP™), and Neurofilament light (Nf-L). Each biomarker has been demonstrated to have significance for the investigation of neurodegeneration and brain injury, and to have utility for monitoring effectiveness of drug discovery and devel…
The Simoa Human Neurology 2-Plex assay (N2PB) measures two important neurology biomarkers in both cerebrospinal fluid (CSF) and blood. The two targets are neurofilament light (Nf-L) and glial fibrillary acidic protein (GFAP™), which have been studied as indicators of traumatic brain injury (TBI) severity. N2PB has been developed as a 2-Plex version of the Neurology 4-Plex B assay (N4PB). *Banyan GFAP™ is a registered tradem…
Sino Biological provides a wide range of influenza virus research reagents and technical services, supporting vaccine safety and immunogenicity assessment and vaccine protective efficacy evaluation.
Sino Biological provides comprehensive solutions for CAR-T cell therapy companies from CAR development, T cell activation, lentivirus packaging, CAR-T cell expansion to CAR-T cell quality control, fully supporting CAR-T research.
Sino Biological has developed a series of high-quality research reagents for dominant SARS-CoV-2 mutants, including recombinant antigens, detection antibodies, ELISA kits, pseudovirus, cDNAs, peptide pools, and receptor ACE2. These variant reagents have actively supported the basic research of SARS-CoV-2 and the development of vaccines, therapeutic antibodies, and diagnostic reagents.
Sino Biological provides comprehensive reagents and services for CAR-NK cell therapy development to support our customers from early target discovery to the preclinical phase of research and development.
Sino Biological has developed an extensive suite of recombinant complement proteins, covering C1s, C2, C3, C5, C7, Factor B, D, H, I and more, advancing the development of novel treatments targeting complement proteins.
Sino Biological offers a comprehensive range of recombinant HER3 proteins and antibodies, facilitating studies on HER3 signaling, protein-protein interactions, and drug efficacy assessments.
Sino Biological provides a comprehensive range of recombinant CEACAM proteins and corresponding CEACAM antibodies for crucial research, aiding investigations into CEACAM interactions with pathogens and their potential in new medical discoveries.
Millipore now proudly offers the MILLIPLEX® MAP Human Cancer Biomarker Panel. The Cancer Biomarker Panel includes both a Five-Plex assay, which simultaneously measures five serum biomarkers, Macrophage Migration Inhibitory Factor (MIF), Prolactin, CA-125, Leptin and Osteopontin (OPN), and a Single Plex IGF-II assay. The combination of the six serum biomarkers that discriminate between disease-free and ovarian cancer patien…
Innova Biosciences – Antibody Conjugation Service Bio-conjugates can be challenging to optimise and time consuming to produce: 1. Too much conjugation may result in the target protein becoming inactive and insoluble. 2. Too little conjugation can result in weak signals. 3. Our competitors require milligrams of your precious material and have a 2 week process time. Fast & FAb™ Antibody Conjugation Service – Innova Biosciences t…
R&D TNF-alpha / TNFSF1A - Recombinant Human Protein Tumor necrosis factor alpha (TNF-alpha), also known as cachectin and TNFSF1A, is the prototypic ligand of the TNF superfamily. It is a pleiotropic molecule that plays a central role in inflammation, apoptosis, and immune system development. Specifications and Use for R&D TNF-alphaSource of R&D TNF• A DNA sequence encoding the mature human TNF-α protein sequence (Accession…
LifeXtend™ conjugate stabilizer/diluent is a proprietary multi-component reagent system that stabilizes antibody-HRP conjugates both at 4°C and at ambient temperature. By using LifeXtend™ HRP stabilizer/diluent in antibody conjugation the HRP conjugate can be stabilized during use and stored as pre-diluted, ready-to-use reagents thus eliminating waste and improving consistency from experiment to experiment. LifeXtend™ shows…
A miniaturized immunoassay capable of simultaneously evaluating multiple biomarkers in a single sub-array. This multiplex assay measures a panel of 10 angiogenesis proteins: ANG, EGF, FGF, HB-EGF, HGF, IL8, Leptin, PIGF, VEGF, and G-CSF plus a positive and a negative control.